【加科思-B 盘中涨超 12%】截至发稿,加科思-B 股价上涨 11.26%,现报 4.15 港元,成交额 3040.22 万港元。加科思发布消息,其自主研发的 SHP2 抑制剂 sitneprotafib 相关研究见刊 ClinicalCancerResearch,公布了临床前体内外数据和代表性患者病例。目前公司正在开展 sitneprotafib 与戈来雷塞联用的 III 期临床试验,这标志着...
Source Link【加科思-B 盘中涨超 12%】截至发稿,加科思-B 股价上涨 11.26%,现报 4.15 港元,成交额 3040.22 万港元。加科思发布消息,其自主研发的 SHP2 抑制剂 sitneprotafib 相关研究见刊 ClinicalCancerResearch,公布了临床前体内外数据和代表性患者病例。目前公司正在开展 sitneprotafib 与戈来雷塞联用的 III 期临床试验,这标志着...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.